| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |